Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2019

View Archived Issues

Roche presents first-in-human data for RO-7062931

HPN-328 targeting DLL3 shows preclinical efficacy and safety for immunotherapy in SCLC

New Smo antagonist shows antitumor activity in medulloblastoma and cholangiocarcinoma animal models

New PEGylated IL-2 with improved pharmacologic properties specifically activates and expands Tregs

Anchiano discontinues phase II Codex study of inodiftagene vixteplasmid in NMIBC

Positive results presented from second phase III psoriasis study of bimekizumab

Results presented from proof-of-concept phase I study of cenerimod

First-in-human data presented for tetrameric bispecific antibody AK-104

DRA inhibitors synthesized for cystic fibrosis-related nephrolithiasis

Gut bacteria can drive heart autoimmunity

Succinate identified as novel cancer therapy target

Sparsentan does not appear to have a negative effect on quality of life in FSGS patients

First-in-human data for novel platelet glycoprotein IIb/IIIa inhibitor RUC-4 in patients with STEMI

Institute for Translational Vaccinology tests RSV vaccine in phase I study

Japanese researchers patent TRPC3 and TRPC6 antagonists

Nippon Chemiphar discloses xanthine oxidase inhibitors

Innate Tumor Immunity identifies NLRP3 agonists

Korean investigators disclose mTORC1 inhibitors

New SCD1 and SCD5 inhibitors presented by Yumanity Therapeutics

Phase I trial studies Rocket's hematopoietic cell-based gene therapy for pyruvate kinase deficiency

Shanghai De Novo studies DN-1508052-01 in phase I for advanced solid tumors

FDA approves Adakveo to reduce vaso-occlusive crises in patients with sickle cell disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...